Catalyst Wire Dossier Catalyst Wire Dossier

Phenazopyridine hydrochloride

phenazopyridine hydrochloride · Amneal Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Phenazopyridine hydrochloride, covering 2013-01-29 to 2014-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI) [Phase 3]

See pricing